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Abstract: We revisit the crossing hazards problem in survival analysis and com-
pare the use of Cox’s semi-parametric model with a parametric non-PH model
from the generalised time-dependent logistic family(GTDL). A set of gastric can-
cer data is analysed and a GTDL gamma-frailty model is shown to explain the
observed data well. The role of heterogeneity in the crossing hazards problem is
discussed.
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1 Introduction
Despite the ubiquity of Cox’s proportional hazards (PH) model it is being
realised increasingly that not all survival data obey the PH assumption.
In multi-factor studies the effect of one or more covariates may be no-
ticeably non-PH. A clear signal is that of crossing hazards. A classical
example is the well-known data set of the Gastrointestinal Tumor Study
Group (GTSG)(1982), reporting the effects of chemotherapy and combined
chemotherapy and radiotherapy on the survival times of gastric cancer pa-
tients (Figure 1). The question then arises as to how best to model these
effects. Sometimes, in practice, non-PH covariates are ignored and they
are analysed as being PH in a larger model, but the optimality of this
expediency is unclear.
An alternative approach is to adopt a model which can cope with non-PH
and PH effects. The Generalised Time-Dependent Logistic family of sur-
vival models contains two non-PH parametric models which are potential
competitors for Cox’s model, namely, the GTDL model (MacKenzie, 1996)
and the logistic accelerated life model, the LAL (Al-tawarah & MacKen-
zie, 2003). Recently, the family has been extended to incorporate frailty
(Blagojevic, MacKenzie & Ha, 2003) and to more general multivariate
forms (Blagojevic & MacKenzie, 2007).
In relation to tests and models developed specifically for crossing hazards
situations per se we refer the reader to Stablein & Koutrouvelis (1985),
Aalen(1994), Hseish (2001) and Bagdonavicius et al (2005).
2 Crossing Hazards
2 Models & Interpretations
Here we take a rather simpler approach when comparing some PH and
non-PH models in the GTDL family in the analysis of crossing hazards
data. In particular, we consider fitting the following set of models to the
gastric cancer data:
λ(t|x) = λ0(t)exp(xβ) (1)
λ(t|u, x) = uλ0(t)exp(xβ) (2)
λ(t|x) = λp(t|x) (3)
λ(t|u, x) = uλp(t|x) (4)
where λ0(·) is an unspecified baseline hazard function, β is a p × 1 vec-
tor of regression parameters associated with fixed covariates, x, λ > 0
is a scalar, U ∼ Gamma with E(U) = 1, V (U) = σ2 and p(t|x) =
exp(tα+ x′β)/1 + exp(tα+ x′β).
2.1 Interpreting λ0(t)
Consider the two group case with a single binary covariate, x. First we note
that in the PH model (1), λ0(t) emerges when x = 0, as the baseline hazard
function. However, it also emerges when β = 0, whence there is no PH
regression. Then the subscript ’0’ is redundant and λ0(t) should be denoted
λ(t), since the hazard is now arbitrary. When β 6= 0 we may proceed
to estimate λ0(t), eg, via Breslow’s method, and compare the resulting
(marginal) survival function with the KM estimator as a check on the
goodness of fit of the model. However, as here, we are dealing with one
covariate indicating two-groups the comparison with KM is not available
when β = 0.
By contrast, the interpretation of parametric models is much clearer, as
when x = 0 or β = 0 the hazard typically reduces to a specific function of
time eg, λ exp(tα)/(1+exp(tα)) in model (3) above, and the corresponding
parametric survival function can always be tested against the KM estimator
as a check on fit.
3 Results
We re-analysed the survival times of the 90 patients with gastric cancer.
Figure 1 shows the KM survival functions in the chemotherapy and com-
bined therapy groups. The crossing survival functions are a clear sign of
non-proportionality and survival is lower in patients receiving combined
therapy for the first three years and thereafter it is better. We fitted the
sequence of models (1)-(4) presented above using (marginal) maximum like-
lihood estimation and the results are shown in Table 1. As expected the PH
MacKenzie & Ha 3
ss
FIGURE 1. KM Survival Functions in Treatment Groups
TABLE 1. Models fitted and their marginal mles & (s.e.)
Model αˆ0 αˆ1 βˆ0 βˆ1 σˆ2 ˆ`
Cox - - - -0.106 - -307.47
- - - (0.223) -
Cox GF - - - -1.146 1.717 -306.50
- - - (0.675) (1.024)
GTDL -0.832 -0.094 1.494 -1.380 - -132.55
(0.242) (0.192) (0.666) (0.822) -
GTDL GF -0.789 3.499 2.380 -4.612 0.400 -127.89
(0.326) (1.408) ( 1.413) (1.676) (0.176)
model cannot cope with this situation - the log-rank test is non-significant
- as indicated by βˆ1 /se(ˆβ1). On the other hand, the generalised Wilcoxon
statistic is (χ2 = 3.96, df = 1,p < 0.05). In a two group comparison with
no explanatory covariates we should examine the role of heterogeneity, via
frailty. Here again the semi-parametric PH model is uninformative. The
GTDL model with separate time parameters for each group (α0 & α1)
is equally unhelpful, but when the GTDL model is extended to Gamma
frailty, all of the resulting parameters are statistically significant, suggest-
ing that the GTDL frailty model provides a satisfactory explanation of the
data. The resulting fit is shown in Figure 2.
4 Crossing Hazards
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FIGURE 2. KM Survival & Fitted GTDL Gamma Frailty Model
4 Discussion
The use of parametric models is convenient when dealing with crossing
hazards data. It is natural, in these circumstances, to consider a non-PH
family such as the GTDL. It might be have been thought that the use of
separate time parameters, which is always a viable strategy with parametric
models, would have been sufficient to capture the structure of the data.
However, our analysis shows clearly the important role of heterogeneity
modelled via the Gamma distribution. In the main paper we will discuss
these issues further and consider alternative frailty distributions including
h-likelihood.
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